Paper26323879
The global burden of IBD: from 2015 to 2025.
Kaplan GG. Nat Rev Gastroenterol Hepatol, 2015. Cited by 2,184 papers, by iCite.
Cite this record
ConductScience Library. The global burden of IBD: from 2015 to 2025. Papers, record 26323879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323879
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cost of Illness | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Environmental Exposure | |
| Environmental Monitoring | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04733456 | Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) Patients | Background | ClinicalTrials.gov | |
| NCT05611866 | A Pilot Study of FMT on CD Patients With AIEC | Background | ClinicalTrials.gov | |
| NCT06553053 | Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial | Background | ClinicalTrials.gov |
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19651626 | Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. | Gut | 2009 | https://conductscience.org/library/papers/19651626 | PubMed |
| 2 | 23516681 | Environment and the inflammatory bowel diseases. | Can J Gastroenterol | 2013 | https://conductscience.org/library/papers/23516681 | PubMed |
| 3 | 11266373 | Smoking cessation and the course of Crohn's disease: an intervention study. | Gastroenterology | 2001 | https://conductscience.org/library/papers/11266373 | PubMed |
| 4 | 2598752 | A meta-analysis of the role of smoking in inflammatory bowel disease. | Dig Dis Sci | 1989 | https://conductscience.org/library/papers/2598752 | PubMed |
| 5 | 14570727 | Incidence and prevalence of ulcerative colitis in Punjab, North India. | Gut | 2003 | https://conductscience.org/library/papers/14570727 | PubMed |
| 6 | 11085842 | The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. | Ann Intern Med | 2000 | https://conductscience.org/library/papers/11085842 | PubMed |
| 7 | 26055136 | Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies. | Gastroenterology | 2015 | https://conductscience.org/library/papers/26055136 | PubMed |
| 8 | 19572377 | Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. | Inflamm Bowel Dis | 2010 | https://conductscience.org/library/papers/19572377 | PubMed |
| 9 | 23604131 | East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. | Gut | 2014 | https://conductscience.org/library/papers/23604131 | PubMed |
| 10 | 24832837 | Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries. | Eur J Health Econ | 2014 | https://conductscience.org/library/papers/24832837 | PubMed |
| 11 | 25350768 | Funding a smoking cessation program for Crohn's disease: an economic evaluation. | Am J Gastroenterol | 2015 | https://conductscience.org/library/papers/25350768 | PubMed |
| 12 | 19466305 | Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. | Arq Gastroenterol | 2009 | https://conductscience.org/library/papers/19466305 | PubMed |
| 13 | 23128233 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | Nature | 2012 | https://conductscience.org/library/papers/23128233 | PubMed |
| 14 | 23166905 | Inflammatory bowel disease: a Canadian burden of illness review. | Can J Gastroenterol | 2012 | https://conductscience.org/library/papers/23166905 | PubMed |
| 15 | 25223575 | Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. | Am J Gastroenterol | 2014 | https://conductscience.org/library/papers/25223575 | PubMed |
| 16 | 12290760 | Health policy in less developed countries: past trends and future directions. | J Int Dev | 1995 | https://conductscience.org/library/papers/12290760 | PubMed |
| 17 | 15168363 | Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15168363 | PubMed |
| 18 | 25732745 | Epidemiology and risk factors for IBD. | Nat Rev Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/25732745 | PubMed |
| 19 | 24037875 | Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. | Gut | 2013 | https://conductscience.org/library/papers/24037875 | PubMed |
| 20 | 14687822 | Risk of early surgery for Crohn's disease: implications for early treatment strategies. | Am J Gastroenterol | 2003 | https://conductscience.org/library/papers/14687822 | PubMed |
Cited by1,394
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,184 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979275 | A probiotic-drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42979275 | PubMed |
| 42952690 | Associations between redox-related biomarkers and treatment response in patients with inflammatory bowel disease initiating infliximab or vedolizumab. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42952690 | PubMed |
| 42920913 | Targeting miR-21 ameliorates colitis by restoring Th17/Treg balance through direct inhibition of Smad7/Ski. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42920913 | PubMed |
| 42909122 | Biologic and small-molecule therapies for inflammatory bowel disease: mechanisms, comparative evidence and the emerging pipeline. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42909122 | PubMed |
| 42899159 | The aryl hydrocarbon receptor and kynurenine pathway: connecting inflammatory bowel disease and depression via the microbiota gut brain axis. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42899159 | PubMed |
| 42897465 | Diagnostic accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) for inflammatory bowel disease: a systematic review and bivariate diagnostic meta-analysis. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42897465 | PubMed |
| 42866443 | Alternative Medicine and Nutritional Therapy in Adult Inflammatory Bowel Disease in India: A Move Towards Holistic Practice. | Cureus | 2026 | https://conductscience.org/library/papers/42866443 | PubMed |
| 42851492 | Ulcerative colitis, but not Crohn's disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification. | Front Immunol | 2026 | https://conductscience.org/library/papers/42851492 | PubMed |
| 42823103 | Patient outcomes and healthcare utilisation following implementation of an advanced therapy care pathway for inflammatory bowel disease: a multicentre, prospective quasi-experimental preimplementation/postimplementation study in the Netherlands. | BMJ Open Gastroenterol | 2026 | https://conductscience.org/library/papers/42823103 | PubMed |
| 42812064 | [Ethyl caffeate alleviates dextran sulfate sodium-induced colitis in mice by restoring intestinal epithelial tight junctions via activating the Wnt/β-Catenin pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/42812064 | PubMed |
| 42801564 | Integrating Genetics With Epidemiological Measurements Identifies Burden QTLs of Inflammatory Bowel Disease across 20 Countries. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42801564 | PubMed |
| 42783218 | Associations Between Anti-TNF Pharmacokinetics, Immunogenicity, and Therapeutic Response in Iraqi Patients with Inflammatory Bowel Disease: A Real-World Therapeutic Drug Monitoring Study. | Diseases | 2026 | https://conductscience.org/library/papers/42783218 | PubMed |
| 42781199 | Microplastics and nanoplastics in inflammatory bowel disease: Mechanistic plausibility, human evidence and future research priorities. | World J Gastrointest Pathophysiol | 2026 | https://conductscience.org/library/papers/42781199 | PubMed |
| 42780487 | Biohybrid magnetic carrier robots for targeted bacteria release in ulcerative colitis. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42780487 | PubMed |
| 42760344 | The exposome and inflammatory bowel disease: a framework for primary and primordial prevention. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42760344 | PubMed |
| 42756163 | Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42756163 | PubMed |
| 42725754 | Adhesion-Enhanced Engineered Probiotic for Prolonged Intestinal Retention and Calprotectin-Responsive IBD Therapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42725754 | PubMed |
| 42708056 | Colon-targeted oral delivery of melatonin for regulating macrophage activity and intestinal barrier in ulcerative colitis. | Theranostics | 2026 | https://conductscience.org/library/papers/42708056 | PubMed |
| 42688144 | The algorithmic epistemic inversion in gastroenterology: how social media and psychological vulnerability fuel secondary risks in IBD and IBS management. | Front Public Health | 2026 | https://conductscience.org/library/papers/42688144 | PubMed |
| 42688076 | IBD-related inflammatory memory and colorectal cancer: epigenetic mechanisms and microbiome interventions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42688076 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26323879
GET https://conductscience.org/api/papers/v1/26323879/references?page=2